- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02817581
NEWS and Rapid Lactate Testing for Early Identification of High Risk Patients in the Emergency Department
Validation of National Early Warning Score (NEWS) and Rapid Lactate Testing for Early Identification of High Risk Patients in the Emergency Department
To validate the NEWS and rapid lactate testing for early identification of high risk [triage Category 3 (urgent)] patients in the Emergency Department.
To compare qSOFA and SIRS criteria in patients in the Emergency Department.
Study Overview
Status
Conditions
Detailed Description
Background:
Sepsis is a potentially life-threatening complication of an infection. Early identification and early intervention are two main elements in improving patient care.
Objectives:
- To validate the NEWS and rapid lactate testing for early identification of high risk [triage Category 3 (urgent)] patients in the Emergency Department.
- To compare qSOFA and SIRS criteria in patients in the Emergency Department.
Study design:
This is a prospective, cohort study. Patients aged 18 or above presenting to the ED triaged as Category 3 (urgent) will be recruited. The required data for calculating NEWS will be collected at triage and triage lactate level will be measured by point-of-care analyzer.
Outcomes:
The primary outcome is referral for intensive care unit (ICU) admission during the patient's ED stay. The secondary outcomes are length of stay in hospital (LOS), hospital admission, admission to ICU, length of ICU-free admission (defined as days alive outside the ICU from admission to day 30) 30-day mortality and time to processes-of-care.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
NT
-
Sha Tin, NT, Hong Kong
- Prince of Wales Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Aged 18 years or above who are triage category 3 in emergency department
- Presenting to emergency department between 9am and 4pm, Monday to Friday
Exclusion Criteria:
- Aged below 18 years
- Pregnant
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
30-day mortality
Time Frame: 30 days after recruitment
|
30 days after recruitment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
referral for intensive care unit (ICU) admission
Time Frame: 24 hr after recruitment
|
24 hr after recruitment
|
|
length of stay in hospital (LOS)
Time Frame: 30 days after recruitment
|
30 days after recruitment
|
|
hospital admission
Time Frame: 30 days after recruitment
|
30 days after recruitment
|
|
admission to ICU
Time Frame: 30 days after recruitment
|
30 days after recruitment
|
|
length of ICU-free admission
Time Frame: 30 days after recruitment
|
30 days after recruitment
|
|
time to processes-of-care
Time Frame: 24 hr after recruitment
|
time to lactate measured, time to antibiotics admission, time to blood culture obtained, time to fluid resuscitation, time to vasopressor administration from ED arrival
|
24 hr after recruitment
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CRE- 2016.236
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Triage Category 3 (Urgent)
-
Chinese University of Hong KongCompleted
-
Yonsei UniversityUnknownSymptomatic Peripheral Artery Disease With Femoropopliteal Lesions | Moderate or Severe Claudication (Rutherford Category 2 or 3) | Critical Limb Ischemia (Rutherford Category 4 or 5)Korea, Republic of
-
Yonsei UniversityCompletedSymptomatic Peripheral Artery Disease With Femoropopliteal Lesions | Moderate or Severe Claudication (Rutherford Category 2 or 3) | Critical Limb Ischemia (Rutherford Category 4 or 5)Korea, Republic of
-
University Hospital, AngersRecruiting